✦ LIBER ✦

c-MET as a prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection

✍ Scribed by Neuzillet, Cindy; Cros, Jerome; Tijeras-Raballand, Annemilaï; Moroch, Juilen; de Mestier, Louis; Bala, Maryse; Bedossa, Pierre; Paradis, Valérie; Sauvanet, Alain; Bachet, Jean-Baptiste; Cvitkovic, Esteban; Raymond, Eric; Couvelard, Anne; Hammel, Pascal

Book ID: 126821388
Publisher: S. Karger AG
Year: 2014
Tongue: English
Weight: 56 KB
Volume: 14
Category: Article
ISSN: 1424-3903
DOI: 10.1016/j.pan.2014.05.665

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Prognostic Value of Clinical and Pat

The Prognostic Value of Clinical and Pathologic Factors in Esophageal Adenocarcinoma: A Mayo Cohort of 796 Patients With Extended Follow-up After Surgical Resection

✍ Yoon, Harry H.; Khan, Maliha; Shi, Qian; Cassivi, Stephen D.; Wu, Tsung-Teh; Que 📂 Article 📅 2010 🏛 Mayo Clinic 🌐 English ⚖ 178 KB

Nucleotide transporters and dCK1 as prog

Nucleotide transporters and dCK1 as prognostic markers for patients with resected pancreatic ductal adenocarcinoma with or without adjuvant gemcitabine or 5FU hENT1 tested with samples from patients randomized in the ESPAC1/3 trials

✍ Neoptolemos, J.P.; Cox, T.F.; Greenhalf, W.; Garner, L.; Campbell, F.; Palmer, D 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 58 KB